Hedge Fund - BioImpact Capital
Verve Therapeutics Inc. (VERV)
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2024 - Q3 (2024-09-30) | $0 | 0% | 0 | $5.81 |
| 2 | 2024 - Q2 (2024-06-30) | $3,114,235 | 0.48% | 638,163 | $6.29 |
| 3 | 2024 - Q1 (2024-03-31) | $8,474,805 | 1.36% | 638,163 | $13.26 |
| 4 | 2023 - Q4 (2023-12-31) | $8,895,992 | 2.08% | 638,163 | $12.40 |
| 5 | 2023 - Q3 (2023-09-30) | $11,376,284 | 3.03% | 857,940 | $16.10 |
| 6 | 2023 - Q2 (2023-06-30) | $16,086,375 | 3.23% | 857,940 | $16.65 |
| 7 | 2023 - Q1 (2023-03-31) | $11,586,484 | 3.01% | 803,501 | $19.58 |
| 8 | 2022 - Q4 (2022-12-31) | $15,647,590 | 4.05% | 808,661 | $26.50 |
| 9 | 2022 - Q3 (2022-09-30) | $21,839,000 | 5.17% | 635,792 | $31.92 |
The displayed share prices are average quarterly stock market prices.